NeuroSTAT

Phase 2Small molecule

NNeuroVive Pharmaceutical AB

NeuroSTAT is one of 13 small molecule programs targeting Head Injury. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Head InjuryActive, not recruiting

Head InjuryPhase 2

Active, not recruiting

Competition

Competitive Landscape

15 competitors in Head Injury

#DrugCompanyPhaseTrials

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 2

Epsom Salt

FFresenius Kabi Oncology Ltd.

Cyklokapron

2 4

Crestor

AstraZeneca

Phase 2

1 5

Human Serum Albumin

FFresenius

Phase 3

1 6

Osmitrol

BB. Braun Medical Inc.

Phase 2

1 7

Depakote

Teva

Preclinical

1 8

Oxycyte

TTenax Therapeutics, Inc.

Phase 2

1 9

Direct Anticoagulant

Bayer

Preclinical

1 10

Cortrosyn

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Head Injury1 trial

Copenhagen Head Injury Ciclosporin (CHIC) Study

Completed·NNeuroVive Pharmaceutical AB·Phase 2·NCT01825044·16 enrolled

Intravenous Administration1 trial

A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers

Completed·NNeuroVive Pharmaceutical AB·Phase 1·NCT01692834·65 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for NeuroSTAT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NeuroSTAT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NeuroSTAT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — NeuroVive Pharmaceutical AB company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNeuroVive Pharmaceutical AB

NeuroSTAT

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Head Injury1 trial

Intravenous Administration1 trial

References

Drug Info

Quick Facts

Related News